Sign in

CIK 0001395937 · Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320162505
Phone
781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. 144 Insider Sale of Securities
  5. 4 Grant or award President, Head of R&D acquired 41,900 shares (grant or award)
  6. 4 Grant or award Chief Financial Officer acquired 41,900 shares (grant or award)
  7. 4 Grant or award Chief Executive Officer acquired 149,500 shares (grant or award)
  8. 4 Grant or award Director acquired 50,000 shares (grant or award)
  9. 4 Grant or award Director acquired 25,000 shares (grant or award)
  10. 4 Grant or award Director acquired 25,000 shares (grant or award)
  11. 4 Grant or award Director acquired 25,000 shares (grant or award)
  12. 4 Grant or award Director acquired 25,000 shares (grant or award)
  13. 4 Grant or award Director acquired 25,000 shares (grant or award)
  14. 4 Grant or award Director acquired 25,000 shares (grant or award)
  15. SCHEDULE 13G Stake Statement of Beneficial Ownership
  16. SCHEDULE 13G Stake Statement of Beneficial Ownership
  17. 8-K Event Executive or director change
  18. SC 13G/A Stake Amended Statement of Ownership
  19. 8-K Event Other events
  20. 8-K Event Other events

Page 6 of 33 · 660 filings